HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637H959. A total of 4 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $229,200 | -11.7% | 6,000 | -16.7% | 0.00% | – |
Q2 2023 | $259,704 | -13.9% | 7,200 | -8.9% | 0.00% | – |
Q1 2023 | $301,701 | -88.0% | 7,900 | -82.1% | 0.00% | -100.0% |
Q4 2022 | $2,509,290 | +145.0% | 44,100 | +70.3% | 0.00% | – |
Q3 2022 | $1,024,000 | +32.3% | 25,900 | +47.2% | 0.00% | – |
Q2 2022 | $774,000 | – | 17,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 294,900 | $2,846,000 | 0.04% |
SIMPLEX TRADING, LLC | 167 | $22,000 | 0.00% |
Citadel Advisors | 16,900 | $163,000 | 0.00% |